HMCN2
gene geneOn this page
Also known as DKFZp434P0216FLJ23816
Summary
HMCN2 (hemicentin 2, HGNC:21293) is a protein-coding gene on chromosome 9q34.11, encoding Hemicentin-2 (Q8NDA2).
Predicted to enable axon guidance receptor activity. Predicted to be involved in homophilic cell adhesion via plasma membrane adhesion molecules and synapse organization. Located in collagen-containing extracellular matrix.
Source: NCBI Gene 256158 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_001291815
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21293 |
| Approved symbol | HMCN2 |
| Name | hemicentin 2 |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434P0216, FLJ23816 |
| Ensembl gene | ENSG00000148357 |
| Ensembl biotype | protein_coding |
| OMIM | 621107 |
| Entrez | 256158 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000428715, ENST00000480829, ENST00000487727, ENST00000611173, ENST00000623487, ENST00000624552, ENST00000683500
RefSeq mRNA: 1 — MANE Select: NM_001291815
NM_001291815
CCDS: CCDS94512
Canonical transcript exons
ENST00000683500 — 98 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000984678 | 130432429 | 130432555 |
| ENSE00001110474 | 130431367 | 130431486 |
| ENSE00001595429 | 130433348 | 130434123 |
| ENSE00001597348 | 130356088 | 130356257 |
| ENSE00001600750 | 130430284 | 130430604 |
| ENSE00001605965 | 130427313 | 130427375 |
| ENSE00001607288 | 130354763 | 130355044 |
| ENSE00001612229 | 130294855 | 130295026 |
| ENSE00001616719 | 130286188 | 130286310 |
| ENSE00001617437 | 130296674 | 130296794 |
| ENSE00001625829 | 130299025 | 130299288 |
| ENSE00001644680 | 130357834 | 130357988 |
| ENSE00001645318 | 130309912 | 130310061 |
| ENSE00001645518 | 130359319 | 130359414 |
| ENSE00001654315 | 130304730 | 130305002 |
| ENSE00001655564 | 130307453 | 130307566 |
| ENSE00001658117 | 130429557 | 130429685 |
| ENSE00001659180 | 130358390 | 130358486 |
| ENSE00001668741 | 130348545 | 130348675 |
| ENSE00001690775 | 130351423 | 130351577 |
| ENSE00001697266 | 130285158 | 130285316 |
| ENSE00001700226 | 130425687 | 130425924 |
| ENSE00001705614 | 130348984 | 130349131 |
| ENSE00001713403 | 130302857 | 130303001 |
| ENSE00001715350 | 130428358 | 130428489 |
| ENSE00001720314 | 130418772 | 130419041 |
| ENSE00001725516 | 130352927 | 130353205 |
| ENSE00001729778 | 130355746 | 130355854 |
| ENSE00001741630 | 130306811 | 130306938 |
| ENSE00001747889 | 130349537 | 130349663 |
| ENSE00001755203 | 130424776 | 130424913 |
| ENSE00001779276 | 130425009 | 130425130 |
| ENSE00001783839 | 130303487 | 130303608 |
| ENSE00001785273 | 130284603 | 130284673 |
| ENSE00001785355 | 130427497 | 130427619 |
| ENSE00001797490 | 130360428 | 130360604 |
| ENSE00001798131 | 130422577 | 130422726 |
| ENSE00001798368 | 130410571 | 130410652 |
| ENSE00001801119 | 130306129 | 130306270 |
| ENSE00001801747 | 130295666 | 130295772 |
| ENSE00001817670 | 130373038 | 130373124 |
| ENSE00001846860 | 130391935 | 130392118 |
| ENSE00001860527 | 130372294 | 130372407 |
| ENSE00001868878 | 130391450 | 130391574 |
| ENSE00001882454 | 130390977 | 130391120 |
| ENSE00001884742 | 130391204 | 130391363 |
| ENSE00001911097 | 130388409 | 130388540 |
| ENSE00001925763 | 130386443 | 130386524 |
| ENSE00003621372 | 130384685 | 130384798 |
| ENSE00003627423 | 130385560 | 130385762 |
| ENSE00003639979 | 130384373 | 130384534 |
| ENSE00003732886 | 130325811 | 130325970 |
| ENSE00003736411 | 130319495 | 130319695 |
| ENSE00003737168 | 130320356 | 130320451 |
| ENSE00003739522 | 130327310 | 130327475 |
| ENSE00003747723 | 130325595 | 130325707 |
| ENSE00003751353 | 130320776 | 130320903 |
| ENSE00003754676 | 130321787 | 130321931 |
| ENSE00003755059 | 130362867 | 130362990 |
| ENSE00003755188 | 130375876 | 130375989 |
| ENSE00003755309 | 130394385 | 130394575 |
| ENSE00003755472 | 130347166 | 130347360 |
| ENSE00003755732 | 130405955 | 130406168 |
| ENSE00003755851 | 130377649 | 130377799 |
| ENSE00003755948 | 130399511 | 130399632 |
| ENSE00003756045 | 130403741 | 130403875 |
| ENSE00003756245 | 130341111 | 130341365 |
| ENSE00003756283 | 130364714 | 130364889 |
| ENSE00003756362 | 130370964 | 130371131 |
| ENSE00003756447 | 130397528 | 130397655 |
| ENSE00003756682 | 130369570 | 130369851 |
| ENSE00003757125 | 130407571 | 130407705 |
| ENSE00003757791 | 130365876 | 130365995 |
| ENSE00003758080 | 130382679 | 130382866 |
| ENSE00003758200 | 130337894 | 130338021 |
| ENSE00003758280 | 130362008 | 130362165 |
| ENSE00003758382 | 130376516 | 130376658 |
| ENSE00003758566 | 130374502 | 130374693 |
| ENSE00003758579 | 130403194 | 130403328 |
| ENSE00003758798 | 130342350 | 130342436 |
| ENSE00003758799 | 130402789 | 130402896 |
| ENSE00003759024 | 130383504 | 130383600 |
| ENSE00003759183 | 130400783 | 130400947 |
| ENSE00003759221 | 130382184 | 130382297 |
| ENSE00003759268 | 130404869 | 130405059 |
| ENSE00003759317 | 130408743 | 130408933 |
| ENSE00003759411 | 130393212 | 130393309 |
| ENSE00003759501 | 130393742 | 130394008 |
| ENSE00003759519 | 130396169 | 130396313 |
| ENSE00003759634 | 130395924 | 130396065 |
| ENSE00003759746 | 130395027 | 130395108 |
| ENSE00003759778 | 130365631 | 130365727 |
| ENSE00003759898 | 130375563 | 130375736 |
| ENSE00003760209 | 130368276 | 130368437 |
| ENSE00003760215 | 130379249 | 130379467 |
| ENSE00003760341 | 130395211 | 130395347 |
| ENSE00003920064 | 130398551 | 130398707 |
| ENSE00003922058 | 130265760 | 130266137 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 94.85.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8111 / max 66.6127, expressed in 194 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 99008 | 0.4450 | 153 |
| 99009 | 0.3661 | 128 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 94.85 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.03 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 90.85 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 90.31 | silver quality |
| saphenous vein | UBERON:0007318 | 90.11 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 89.51 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 88.80 | gold quality |
| apex of heart | UBERON:0002098 | 87.60 | gold quality |
| body of uterus | UBERON:0009853 | 87.43 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.40 | gold quality |
| small intestine | UBERON:0002108 | 86.65 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 86.25 | gold quality |
| transverse colon | UBERON:0001157 | 86.17 | gold quality |
| lower esophagus | UBERON:0013473 | 85.39 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 85.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.30 | gold quality |
| colon | UBERON:0001155 | 84.94 | gold quality |
| kidney epithelium | UBERON:0004819 | 84.87 | gold quality |
| large intestine | UBERON:0000059 | 84.38 | gold quality |
| intestine | UBERON:0000160 | 84.23 | gold quality |
| ectocervix | UBERON:0012249 | 83.66 | gold quality |
| endocervix | UBERON:0000458 | 83.48 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.21 | gold quality |
| muscle of leg | UBERON:0001383 | 83.06 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 82.54 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 81.80 | gold quality |
| upper arm skin | UBERON:0004263 | 81.49 | gold quality |
| vena cava | UBERON:0004087 | 80.75 | silver quality |
| mucosa of stomach | UBERON:0001199 | 80.41 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 80.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 13.76 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting HMCN2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-3196 | 98.96 | 63.91 | 326 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-3180 | 98.46 | 64.68 | 348 |
| HSA-MIR-3180-3P | 98.46 | 64.68 | 348 |
| HSA-MIR-6816-5P | 98.46 | 64.35 | 364 |
| HSA-MIR-188-5P | 97.89 | 67.01 | 756 |
| HSA-MIR-6866-3P | 97.38 | 66.94 | 748 |
| HSA-MIR-2276-5P | 96.27 | 65.85 | 937 |
| HSA-MIR-6823-5P | 96.26 | 65.69 | 919 |
| HSA-MIR-4787-5P | 89.08 | 66.18 | 88 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hmcn2 | ENSMUSG00000055632 |
| rattus_norvegicus | Hmcn2 | ENSRNOG00000064166 |
Paralogs (36): CNTN1 (ENSG00000018236), CDON (ENSG00000064309), NEO1 (ENSG00000067141), SDK2 (ENSG00000069188), IGSF9B (ENSG00000080854), IGSF9 (ENSG00000085552), NRCAM (ENSG00000091129), MXRA5 (ENSG00000101825), IGDCC4 (ENSG00000103742), CNTN3 (ENSG00000113805), IGSF21 (ENSG00000117154), CNTN6 (ENSG00000134115), CHL1 (ENSG00000134121), PTPRQ (ENSG00000139304), CNTN4 (ENSG00000144619), BOC (ENSG00000144857), SDK1 (ENSG00000146555), NCAM1 (ENSG00000149294), CNTN5 (ENSG00000149972), IGSF10 (ENSG00000152580), ROBO4 (ENSG00000154133), ROBO3 (ENSG00000154134), NCAM2 (ENSG00000154654), VCAM1 (ENSG00000162692), NFASC (ENSG00000163531), PRTG (ENSG00000166450), ROBO1 (ENSG00000169855), DSCAM (ENSG00000171587), IGDCC3 (ENSG00000174498), VSIG10 (ENSG00000176834), DSCAML1 (ENSG00000177103), CNTN2 (ENSG00000184144), ROBO2 (ENSG00000185008), VSIG10L (ENSG00000186806), DCC (ENSG00000187323), L1CAM (ENSG00000198910)
Protein
Protein identifiers
Hemicentin-2 — Q8NDA2 (reviewed: Q8NDA2)
All UniProt accessions (4): Q8NDA2, A0A087WY63, A0A096LPG1, H0Y3X1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted. Extracellular space. Extracellular matrix. Cleavage furrow.
Miscellaneous. Gene prediction based on partial EST and mRNA data. Gene prediction based on partial EST and mRNA data. Dubious isoform produced through intron retention.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NDA2-5 | 2 | yes |
| Q8NDA2-1 | 1 | |
| Q8NDA2-4 | 3 |
RefSeq proteins (1): NP_001278744* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000152 | EGF-type_Asp/Asn_hydroxyl_site | PTM |
| IPR000742 | EGF | Domain |
| IPR001881 | EGF-like_Ca-bd_dom | Domain |
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR006605 | G2_nidogen/fibulin_G2F | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR009017 | GFP | Homologous_superfamily |
| IPR009030 | Growth_fac_rcpt_cys_sf | Homologous_superfamily |
| IPR013098 | Ig_I-set | Domain |
| IPR013106 | Ig_V-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR018097 | EGF_Ca-bd_CS | Conserved_site |
| IPR026823 | cEGF | Domain |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR036465 | vWFA_dom_sf | Homologous_superfamily |
| IPR049883 | NOTCH1_EGF-like | Domain |
| IPR050958 | Cell_Adh-Cytoskel_Orgn | Family |
| IPR056475 | GBD_Hemicentin/VWA7 | Domain |
| IPR056861 | HMCN1-like_VWA | Domain |
Pfam: PF07474, PF07645, PF07679, PF12662, PF13927, PF23560, PF25106
UniProt features (156 total): disulfide bond 56, domain 49, glycosylation site 40, splice variant 4, sequence conflict 2, modified residue 2, signal peptide 1, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
No AlphaFold model available for Q8NDA2 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 912, 917
Disulfide bonds (56): 1095–1144, 1186–1229, 1273–1323, 1367–1416, 1460–1510, 1554–1603, 1648–1697, 1741–1790, 1833–1874, 1916–1965, 2008–2059, 2101–2150, 2193–2244, 2289–2338, 2383–2432, 2476–2525, 2572–2621, 2670–2719, 2781–2830, 2876–2925 …
Glycosylation sites (40): 329, 346, 379, 478, 525, 547, 674, 1024, 1072, 1268, 1354, 1537, 1563, 1671, 1820, 1909, 2009, 2088, 2094, 2252 …
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 60 (showing top):
GOBP_NEUROGENESIS, GOBP_CELL_CELL_ADHESION, GOBP_CELL_JUNCTION_ORGANIZATION, GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_BASEMENT_MEMBRANE, PETRETTO_HEART_MASS_QTL_CIS_UP, GOCC_CELL_DIVISION_SITE, GOCC_PLASMA_MEMBRANE_REGION, GOCC_CELL_BODY, GOCC_SOMATODENDRITIC_COMPARTMENT, GOCC_AXON, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_STRUCTURAL_MOLECULE_ACTIVITY
GO Biological Process (4): homophilic cell-cell adhesion (GO:0007156), synapse organization (GO:0050808), cell adhesion (GO:0007155), axon guidance (GO:0007411)
GO Molecular Function (3): calcium ion binding (GO:0005509), axon guidance receptor activity (GO:0008046), extracellular matrix structural constituent (GO:0005201)
GO Cellular Component (10): extracellular region (GO:0005576), basement membrane (GO:0005604), plasma membrane (GO:0005886), cell cortex (GO:0005938), cell junction (GO:0030054), axon (GO:0030424), extracellular matrix (GO:0031012), cleavage furrow (GO:0032154), neuronal cell body (GO:0043025), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| extracellular matrix | 2 |
| cell periphery | 2 |
| cell-cell adhesion | 1 |
| cell junction organization | 1 |
| cellular process | 1 |
| axonogenesis | 1 |
| neuron projection guidance | 1 |
| metal ion binding | 1 |
| transmembrane signaling receptor activity | 1 |
| axon guidance | 1 |
| structural molecule activity | 1 |
| membrane | 1 |
| cytoplasm | 1 |
| neuron projection | 1 |
| external encapsulating structure | 1 |
| cell division site | 1 |
| plasma membrane region | 1 |
| somatodendritic compartment | 1 |
| cell body | 1 |
Protein interactions and networks
STRING
646 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HMCN2 | SLC36A3 | Q495N2 | 556 |
| HMCN2 | HDGFL3 | Q9Y3E1 | 447 |
| HMCN2 | GPX3 | P22352 | 409 |
| HMCN2 | NTM | Q9P121 | 397 |
| HMCN2 | PON3 | Q15166 | 371 |
| HMCN2 | OR14A16 | Q8NHC5 | 369 |
| HMCN2 | OR11L1 | Q8NGX0 | 358 |
| HMCN2 | OR6F1 | Q8NGZ6 | 331 |
| HMCN2 | SLAMF1 | Q13291 | 329 |
| HMCN2 | RIBC1 | Q8N443 | 325 |
| HMCN2 | DEPDC4 | Q8N2C3 | 325 |
| HMCN2 | FAM47A | Q5JRC9 | 322 |
| HMCN2 | FREM2 | Q5SZK8 | 320 |
| HMCN2 | KRTAP4-8 | Q9BYQ9 | 320 |
| HMCN2 | NPIPB12 | F8W0I5 | 302 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A140LHF2, A0JPB1, A2AJ76, A7LCJ3, A8E0Y8, E7FF10, O00241, O60500, P01874, P03988, P04221, P0DOX2, P0DOX3, P0DOX4, P0DOX6, P0DP72, P32507, P35590, P43121, P50895, Q06805, Q06806, Q148M6, Q15109, Q5TFQ8, Q5U5A3, Q5XI43, Q62230, Q62786, Q8HW98, Q8NDA2, Q8R2Y2, Q92154, Q923P0, Q93033, Q95KI3, Q96MS0, Q9BRK3, Q9BZZ2, Q9DBV4
Diamond homologs: A0N0X6, A2AJ76, A2CG49, A4IGL7, A4IIW9, B3NS99, B4GBH0, B4HNW4, B4KPU0, B4MR28, B4P5Q9, B4QC63, G5EBF1, O75325, O95428, P0C6S8, P11627, P12960, P22063, P28685, P32004, P97924, Q02246, Q07409, Q09024, Q12860, Q290N5, Q32Q07, Q3UQ28, Q3URE9, Q3V1M1, Q5R482, Q61330, Q61809, Q62682, Q62845, Q63198, Q66HV9, Q69Z26, Q6AWJ9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 32 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1264 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:130400778:TTTA:T | acceptor_loss | 1.0000 |
| 9:130400781:A:AG | acceptor_gain | 1.0000 |
| 9:130400781:AGTG:A | acceptor_loss | 1.0000 |
| 9:130400782:G:GA | acceptor_gain | 1.0000 |
| 9:130400782:G:GC | acceptor_loss | 1.0000 |
| 9:130400782:GT:G | acceptor_gain | 1.0000 |
| 9:130400782:GTGC:G | acceptor_gain | 1.0000 |
| 9:130402784:A:AG | acceptor_gain | 1.0000 |
| 9:130402787:A:AG | acceptor_gain | 1.0000 |
| 9:130402787:AGGC:A | acceptor_gain | 1.0000 |
| 9:130402788:G:GA | acceptor_gain | 1.0000 |
| 9:130402788:GGC:G | acceptor_gain | 1.0000 |
| 9:130402788:GGCG:G | acceptor_gain | 1.0000 |
| 9:130402788:GGCGC:G | acceptor_gain | 1.0000 |
| 9:130402892:GCAAG:G | donor_gain | 1.0000 |
| 9:130402896:GGTAA:G | donor_loss | 1.0000 |
| 9:130402897:G:GG | donor_gain | 1.0000 |
| 9:130402897:G:T | donor_loss | 1.0000 |
| 9:130402898:T:G | donor_loss | 1.0000 |
| 9:130403192:A:AG | acceptor_gain | 1.0000 |
| 9:130403193:G:GG | acceptor_gain | 1.0000 |
| 9:130403193:GC:G | acceptor_gain | 1.0000 |
| 9:130403193:GCC:G | acceptor_gain | 1.0000 |
| 9:130403307:G:GT | donor_gain | 1.0000 |
| 9:130403308:A:T | donor_gain | 1.0000 |
| 9:130403329:G:GG | donor_gain | 1.0000 |
| 9:130403329:G:T | donor_loss | 1.0000 |
| 9:130403360:G:T | donor_gain | 1.0000 |
| 9:130403738:CA:C | acceptor_loss | 1.0000 |
| 9:130403739:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
32621 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:130433539:T:G | F5009C | 0.998 |
| 9:130349649:G:C | W1471C | 0.997 |
| 9:130349649:G:T | W1471C | 0.997 |
| 9:130375682:T:A | W2583R | 0.997 |
| 9:130375682:T:C | W2583R | 0.997 |
| 9:130376641:T:A | W2681R | 0.997 |
| 9:130376641:T:C | W2681R | 0.997 |
| 9:130349647:T:A | W1471R | 0.996 |
| 9:130349647:T:C | W1471R | 0.996 |
| 9:130362115:T:A | W2019R | 0.996 |
| 9:130362115:T:C | W2019R | 0.996 |
| 9:130375926:T:G | Y2618D | 0.996 |
| 9:130379413:T:A | W2792R | 0.996 |
| 9:130379413:T:C | W2792R | 0.996 |
| 9:130406141:T:A | W4156R | 0.996 |
| 9:130406141:T:C | W4156R | 0.996 |
| 9:130406143:G:C | W4156C | 0.996 |
| 9:130406143:G:T | W4156C | 0.996 |
| 9:130375684:G:C | W2583C | 0.995 |
| 9:130375684:G:T | W2583C | 0.995 |
| 9:130379415:G:C | W2792C | 0.995 |
| 9:130379415:G:T | W2792C | 0.995 |
| 9:130388516:T:A | W3166R | 0.995 |
| 9:130388516:T:C | W3166R | 0.995 |
| 9:130362117:G:C | W2019C | 0.994 |
| 9:130362117:G:T | W2019C | 0.994 |
| 9:130365985:G:C | W2204C | 0.994 |
| 9:130365985:G:T | W2204C | 0.994 |
| 9:130375927:A:C | Y2618S | 0.994 |
| 9:130376643:G:C | W2681C | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000027245 (9:130403691 G>C), RS1000040159 (9:130363205 A>C,G), RS1000070783 (9:130431713 C>T), RS1000103153 (9:130291897 G>T), RS1000107315 (9:130327859 C>T), RS1000117752 (9:130266133 C>A,T), RS1000151602 (9:130397091 A>G), RS1000151958 (9:130339013 A>T), RS1000162700 (9:130383511 C>T), RS1000199174 (9:130407019 G>A), RS1000203606 (9:130312375 G>A), RS1000234089 (9:130383332 G>A,T), RS1000235233 (9:130357974 G>A,C,T), RS1000240779 (9:130342478 C>T), RS1000255601 (9:130265884 G>T)
Disease associations
OMIM: gene MIM:621107 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005905_8 | Global electrical heterogeneity phenotypes | 2.000000e-10 |
| GCST005905_9 | Global electrical heterogeneity phenotypes | 2.000000e-09 |
| GCST009006_1 | Bicuspid aortic valve without aortic dilation | 2.000000e-06 |
| GCST90011899_69 | Aspartate aminotransferase levels | 3.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004327 | electrocardiography |
| EFO:0004736 | aspartate aminotransferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| methyleugenol | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| abrine | increases expression | 1 |
| eprenetapopt | affects expression, affects reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | decreases expression | 1 |
| Benztropine | affects cotreatment, increases expression | 1 |
| Cuprizone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Methotrexate | increases expression | 1 |
| Oxygen | increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Aflatoxin B1 | affects methylation, increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.